Literature DB >> 29496089

Colon Cancer: Inflammation-Associated Cancer.

Sherief Shawki1, Jean Ashburn1, Steven A Signs2, Emina Huang3.   

Abstract

Colitis-associated cancer is a relatively rare form of cancer with an unclear pathogenesis. Colitis-associated cancer serves as a prototype of inflammation-associated cancers. Advanced colonoscopic techniques are considered standard of care for surveillance in patients with long-standing colitis, especially those with other risk factors, including sclerosing cholangitis and a family history of colorectal cancer. When colitis-associated cancer is diagnosed, the standard operation involves total proctocolectomy. Restorative procedures and surveillance after colectomy require special considerations. In these contexts, new 3-dimensional human models may be used to usher in personalized medicine.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3D human models; Colitis cancer surveillance; Colitis-associated cancer; Colitis-associated cancer management

Mesh:

Year:  2017        PMID: 29496089      PMCID: PMC5836482          DOI: 10.1016/j.soc.2017.11.003

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  86 in total

Review 1.  Dysplasia and Cancer in Inflammatory Bowel Disease.

Authors:  Lyen C Huang; Amit Merchea
Journal:  Surg Clin North Am       Date:  2017-06       Impact factor: 2.741

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94.

Authors:  Rainer Fietkau; Claus Rödel; Werner Hohenberger; Rudolf Raab; Clemens Hess; Torsten Liersch; Heinz Becker; Christian Wittekind; Matthias Hutter; Eva Hager; Johann Karstens; Hermann Ewald; Norbert Christen; Michael Jagoditsch; Peter Martus; Rolf Sauer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

Review 4.  Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Authors:  Lauranne A A P Derikx; Loes H C Nissen; Lisa J T Smits; Bo Shen; Frank Hoentjen
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

5.  Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.

Authors:  M O Blackstone; R H Riddell; B H Rogers; B Levin
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

6.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

Review 7.  From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.

Authors:  Maurizio Romano; Francesco DE Francesco; Laura Zarantonello; Cesare Ruffolo; Giuseppe A Ferraro; Giacomo Zanus; Antonio Giordano; Nicolò Bassi; Umberto Cillo
Journal:  Anticancer Res       Date:  2016-04       Impact factor: 2.480

8.  Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.

Authors:  James F Marion; Jerome D Waye; Daniel H Present; Yuriy Israel; Carol Bodian; Noam Harpaz; Mark Chapman; Steven Itzkowitz; Adam F Steinlauf; Maria T Abreu; Thomas A Ullman; James Aisenberg; Lloyd Mayer
Journal:  Am J Gastroenterol       Date:  2008-09       Impact factor: 10.864

9.  Manometric and functional comparison of ileal pouch anal anastomosis with and without anal manipulation.

Authors:  W Tuckson; I Lavery; V Fazio; J Oakley; J Church; J Milsom
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

10.  Dysplasia and DNA aneuploidy in a pelvic pouch. Report of a case.

Authors:  R Löfberg; L Liljeqvist; K Lindquist; B Veress; F P Reinholt; B Tribukait
Journal:  Dis Colon Rectum       Date:  1991-03       Impact factor: 4.585

View more
  24 in total

1.  CircRNAs as promising biomarkers of inflammatory bowel disease and its associated-colorectal cancer.

Authors:  Yuting Xu; Xinwei Xu; Dickson Kofi Wiredu Ocansey; Hua Cao; Wei Qiu; Qiang Tu; Fei Mao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  TiaochangXiaoliu decoction inhibits azomethane (AOM)/dextran sulfate sodium (DSS)-induced colorectal cancer by regulating immune response.

Authors:  Kefang Chen; Beiping Zhang; Jianjun Li; Aizhen Pan; Linhui Cao; Xiying Zhao; Suiping Huang; Liudan Chen
Journal:  J Gastrointest Oncol       Date:  2021-10

3.  Epigallocatechin-3-gallate inhibits the formation of neutrophil extracellular traps and suppresses the migration and invasion of colon cancer cells by regulating STAT3/CXCL8 pathway.

Authors:  Zhuoxian Zhang; Qiuli Zhu; Siya Wang; Chao Shi
Journal:  Mol Cell Biochem       Date:  2022-09-16       Impact factor: 3.842

4.  Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis.

Authors:  Yongming Huang; Xiaoyuan Zhang; Yansen Li; Jie Yao
Journal:  BMC Genom Data       Date:  2022-06-22

5.  Urolithin A gains in antiproliferative capacity by reducing the glycolytic potential via the p53/TIGAR axis in colon cancer cells.

Authors:  Elisabeth Norden; Elke H Heiss
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

6.  MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-κB activity to inhibit cell proliferation and invasion in colorectal cancer.

Authors:  Mingming Zhu; Wen Zhang; Jun Ma; Youguo Dai; Qi Zhang; Qin Liu; Burong Yang; Gang Li
Journal:  Exp Ther Med       Date:  2019-09-20       Impact factor: 2.447

7.  Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p/STC1 Axis.

Authors:  Chunyan Luan; Yongzhu Li; Zhigang Liu; Cunxin Zhao
Journal:  Onco Targets Ther       Date:  2020-04-30       Impact factor: 4.147

8.  Quercetin Suppresses AOM/DSS-Induced Colon Carcinogenesis through Its Anti-Inflammation Effects in Mice.

Authors:  Rui Lin; Meiyu Piao; Yan Song; Chunyan Liu
Journal:  J Immunol Res       Date:  2020-05-21       Impact factor: 4.818

9.  E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.

Authors:  Jiaoe Chen; Chaoju Gong; Huiqin Mao; Zhaoyun Li; Zejun Fang; Qiang Chen; Min Lin; Xiang Jiang; Yanyan Hu; Wei Wang; Xiaomin Zhang; Xianjun Chen; Hongzhang Li
Journal:  Int J Oncol       Date:  2018-06-05       Impact factor: 5.650

10.  Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer.

Authors:  Fangfang Sun; Weiwei Liang; Kejun Tang; Mengying Hong; Jing Qian
Journal:  PeerJ       Date:  2019-08-26       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.